MarketCap
Facebook
X
TelegramAnnual report 2022
added 03-30-2023
Country |
 USA |
IPO year |
2015 |
Industry |
Diagnostics research |
Stock Exchange |
NASDAQ CAPITAL |
Shares |
889 K |
Market Cap[1] |
$ 1.06 M |
EBITDA (LTM) |
$ -19.8 M |
P/E (LTM) |
- |
P/S (LTM) |
0.17 |
EPS (LTM) |
-2.36 |
Other stocks of industry "Diagnostics research"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
 |
Anixa Biosciences
ANIX
|
$ 2.89 | -2.36 % | $ 93.8 K | Nasdaq Capital Market | USA |
 |
Centogene N.V.
CNTG
|
- | -6.23 % | $ 30.6 M | Nasdaq Global Market |  Germany |
 |
Agilent Technologies
A
|
$ 118.02 | -0.13 % | $ 35.9 B | NYSE,SPB | USA |
 |
Fulgent Genetics
FLGT
|
$ 14.12 | -0.56 % | $ 427 M | Nasdaq Global Market | USA |
 |
Celcuity
CELC
|
$ 107.49 | -0.75 % | $ 4.24 B | Nasdaq Global Select Market | USA |
 |
ICON Public Limited Company
ICLR
|
$ 108.18 | -0.08 % | $ 8.92 B | Nasdaq Global Select Market,SPB |  Irlanda |
 |
IDEXX Laboratories
IDXX
|
$ 634.16 | -0.4 % | $ 51 B | Nasdaq Global Select Market,SPB | USA |
 |
Illumina
ILMN
|
$ 130.4 | -1.88 % | $ 20.7 B | Nasdaq Global Select Market,SPB | USA |
|
Akumin
AKU
|
- | -17.87 % | $ 25.9 M | Nasdaq Capital Market |  Canada |
 |
Castle Biosciences
CSTL
|
$ 27.85 | -0.52 % | $ 774 M | Nasdaq Global Market,SPB | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
- | - | $ 562 M | Nasdaq Global Select Market |  Britain |
 |
Laboratory Corporation of America Holdings
LH
|
$ 282.57 | -1.29 % | $ 23.5 B | NYSE,SPB | USA |
 |
Lantheus Holdings
LNTH
|
$ 77.51 | 1.58 % | $ 5.23 B | Nasdaq Global Select Market,SPB | USA |
 |
Charles River Laboratories International
CRL
|
$ 176.82 | -1.0 % | $ 8.76 B | NYSE,SPB | USA |
 |
Aspira Women's Health
AWH
|
- | -6.19 % | $ 10.5 M | Nasdaq Capital Market,SPB | USA |
 |
Accelerate Diagnostics
AXDX
|
- | -61.36 % | $ 2.46 M | Nasdaq Global Select Market | USA |
 |
Mettler-Toledo International
MTD
|
$ 1 312.12 | -0.98 % | $ 27 B | NYSE,SPB |  Schweiz |
 |
Myriad Genetics
MYGN
|
$ 5.2 | 3.73 % | $ 482 M | Nasdaq Global Select Market,SPB | USA |
 |
NeoGenomics
NEO
|
$ 9.41 | -0.95 % | $ 1.21 B | Nasdaq Global Select Market,SPB | USA |
 |
Global Cord Blood Corporation
CO
|
- | - | $ 399 M | NYSE |  China |
 |
Natera
NTRA
|
$ 208.19 | 4.01 % | $ 20.5 B | Nasdaq Global Select Market,SPB | USA |
 |
Fluidigm Corporation
FLDM
|
- | 1.08 % | $ 308 M | Nasdaq Global Select Market | USA |
 |
Genetic Technologies Limited
GENE
|
- | - | $ 7.1 B | Nasdaq Capital Market |  Australia |
 |
Genetron Holdings Limited
GTH
|
- | 0.12 % | $ 80.1 M | Nasdaq Global Market | China |
 |
Pacific Biosciences of California
PACB
|
$ 1.54 | -5.25 % | $ 462 M | Nasdaq Global Select Market,SPB | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
- | - | $ 10.7 B | Nasdaq Global Select Market | USA |
 |
Precipio
PRPO
|
$ 24.44 | -0.99 % | $ 31.7 M | Nasdaq Global Select Market | USA |
|
Biodesix
BDSX
|
$ 16.16 | 2.6 % | $ 2.1 B | Nasdaq Global Market | USA |
 |
Biocept
BIOC
|
- | -13.05 % | $ 7.29 M | Nasdaq Capital Market | USA |
 |
Senseonics Holdings
SENS
|
$ 7.31 | -11.75 % | $ 305 M | NYSE American | USA |
 |
Sotera Health Company
SHC
|
$ 15.78 | -0.77 % | $ 4.48 B | Nasdaq Global Select Market | USA |
 |
BioNano Genomics
BNGO
|
$ 1.11 | -2.96 % | $ 1.41 M | Nasdaq Capital Market,SPB | USA |
 |
Quest Diagnostics Incorporated
DGX
|
$ 207.65 | -1.24 % | $ 23 B | NYSE,SPB | USA |
 |
Soleno Therapeutics
SLNO
|
$ 38.24 | -2.1 % | $ 1.94 B | Nasdaq Capital Market | USA |
 |
Danaher Corporation
DHR
|
$ 202.6 | -1.6 % | $ 144 B | NYSE,SPB | USA |
 |
Exact Sciences Corporation
EXAS
|
$ 103.35 | - | $ 19.5 B | Nasdaq Capital Market,SPB | USA |
 |
Bioventus
BVS
|
$ 8.8 | 0.34 % | $ 551 M | Nasdaq Global Select Market | USA |
 |
DarioHealth Corp.
DRIO
|
$ 10.5 | -2.33 % | $ 298 M | Nasdaq Capital Market |  Israel |
 |
DexCom
DXCM
|
$ 73.0 | -1.06 % | $ 28.5 B | Nasdaq Global Select Market,SPB | USA |
 |
Thermo Fisher Scientific
TMO
|
$ 507.8 | -0.13 % | $ 191 B | NYSE,SPB | USA |
 |
QIAGEN N.V.
QGEN
|
- | - | $ 10.6 B | NYSE |  Niderland |
 |
Twist Bioscience Corporation
TWST
|
$ 46.79 | 1.95 % | $ 2.8 B | Nasdaq Global Select Market,SPB | USA |
 |
Burning Rock Biotech Limited
BNR
|
$ 24.2 | -3.82 % | $ 254 M | Nasdaq Global Market | China |
 |
CareDx, Inc
CDNA
|
$ 18.64 | -0.56 % | $ 993 M | Nasdaq Global Market,SPB | USA |
 |
VolitionRx Limited
VNRX
|
$ 0.2 | -2.51 % | $ 19.2 M | NYSE American |  Singapore |
 |
Waters Corporation
WAT
|
$ 309.78 | 0.86 % | $ 18.4 B | NYSE,SPB | USA |
 |
Chembio Diagnostics
CEMI
|
- | 0.22 % | $ 16.8 M | Nasdaq Capital Market | USA |
 |
Check-Cap Ltd.
CHEK
|
- | - | $ 9.42 M | Nasdaq Capital Market | Israel |
 |
Guardant Health
GH
|
$ 93.28 | 1.14 % | $ 11.7 B | Nasdaq Global Select Market,SPB | USA |
 |
IQVIA Holdings
IQV
|
$ 173.24 | -0.6 % | $ 29.8 B | NYSE,SPB | USA |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.